Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]
News [4632]
Articles [192]
Editorials [8]
Conferences [135]
elearning [9]
ASH 2016 : Reducing or stopping TKI for CML can be safe, beneficial for some patients
ASH 2016 : Reducing or stopping TKI for CML can be safe, beneficial for some patients
ASH 2016: New CAR-T treatment holds promise for children and young adults with hard-to-treat leukaemia
ASH 2016: New CAR-T treatment holds promise for children and young adults with hard-to-treat leukaemia
Disabling critical 'node' revs up attack when cancer immunotherapies fall short
Disabling critical 'node' revs up attack when cancer immunotherapies fall short
Study reveals new role for Hippo pathway in suppressing cancer immunity
Study reveals new role for Hippo pathway in suppressing cancer immunity
Proposed biosimilar drug shows potential as breast cancer treatment
Proposed biosimilar drug shows potential as breast cancer treatment
Last Month in Oncology with Dr. Bishal Gyawali: November 2016
Last Month in Oncology with Dr. Bishal Gyawali: November 2016
Revolution in our understanding of cancer’ sees dramatic responses to targeted treatments in advanced cancers
Revolution in our understanding of cancer’ sees dramatic responses to targeted treatments in advanced cancers
Stanford researchers develop new compound to reduce tumour growth
Stanford researchers develop new compound to reduce tumour growth
DNA modifications in glioblastoma
DNA modifications in glioblastoma
In highly lethal type of leukaemia, cancer gene predicts treatment response
In highly lethal type of leukaemia, cancer gene predicts treatment response

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation